Cart
sales@molnova.com
Nicotinoyl azide
CAS No. 4013-72-3
Nicotinoyl azide( NAz | N Az | N-Az )
Catalog No. M27781 CAS No. 4013-72-3
Nicotinoyl azide is a probe of light-activated chemical. It has been used to measure the solvent accessibility of purine nucleobases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 38 | Get Quote |
|
| 10MG | 61 | Get Quote |
|
| 25MG | 123 | Get Quote |
|
| 50MG | 198 | Get Quote |
|
| 100MG | 305 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNicotinoyl azide
-
NoteResearch use only, not for human use.
-
Brief DescriptionNicotinoyl azide is a probe of light-activated chemical. It has been used to measure the solvent accessibility of purine nucleobases.
-
DescriptionNicotinoyl azide is a probe of light-activated chemical. It has been used to measure the solvent accessibility of purine nucleobases.
-
In Vitro——
-
In Vivo——
-
SynonymsNAz | N Az | N-Az
-
PathwayOthers
-
TargetOther Targets
-
RecptorAntibiotic
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number4013-72-3
-
Formula Weight148.125
-
Molecular FormulaC6H4N4O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[N-]=[N+]=NC(=O)c1cccnc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wise DR, et al. Glutamine addiction: a new therapeutic target in cancer. Trends Biochem Sci. 2010 Aug;35(8):427-33.
molnova catalog
related products
-
Naratriptan hydrochl...
Naratriptan Hydrochloride is the hydrochloride salt form of naratriptan, a sulfonamide with selective serotonin (5-HT) 1 receptor agonistic activity and anti-migraine property.
-
[D-Phe12]-Bombesin
[D-Phe12]-Bombesin is a derivative of Bombesin and an antagonist for bombesin receptor with Ki of 4.7 μM. [D-Phe12]-Bombesin inhibits the Bombesin -induced amylase release, with IC50 of 4 μM.
-
EZH2-IN-2
EZH2-IN-2 is a EZH2 inhibitor extracted from patent WO2018133795A1, Compound Example 69, with an IC50 of 64 nM. EZH2-IN-2 can be used for the research of cancer or precancerous condition related to EZH2 activity.
